| 1 |
Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial |
|
| | Vasanop Vachiramon, Tanaporn Anuntrangsee, Pasita Palakornkitti, Natthachat Jurairattanaporn, Sarawin Harnchoowong | | | Toxins. 2022; 14(6): 417 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Pigmentation Disorders in the Elderly |
|
| | Andrew M. Armenta,Emily D. Henkel,Ammar M. Ahmed | | | Drugs & Aging. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment |
|
| | Neelam A. Vashi,Stephen A. Wirya,Meyene Inyang,Roopal V. Kundu | | | American Journal of Clinical Dermatology. 2016; | | | [Pubmed] [Google Scholar] [DOI] | |
|
